tanshinone has been researched along with Hypertension, Renovascular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JW; Fang, J; Gao, J; Huang, HQ; Liu, PQ; Tang, FT; Wang, P; Xu, SW; Zhou, SG | 1 |
| Bao, Y; Fang, J; Gao, J; Liu, P; Mou, YG; Pi, R; Wang, P; Wu, X; Zhou, S | 1 |
2 other study(ies) available for tanshinone and Hypertension, Renovascular
| Article | Year |
|---|---|
Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
Topics: Abietanes; Animals; Blood Pressure; Cardiovascular Agents; Collagen; Drugs, Chinese Herbal; Fibrosis; Gene Expression; Heart; Hypertension, Renovascular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Phytotherapy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Salvia miltiorrhiza; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Valine; Valsartan | 2010 |
Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.
Topics: Abietanes; Animals; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Fibrosis; Heart Diseases; Hemodynamics; Hypertension, Renovascular; Male; Myocardium; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2011 |